N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide

C21H15BrN6OS — CID 50786995

IUPACN-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide
SMILESO=C(CSc1nnc2c3cc(-c4ccccc4)nn3ccn12)Nc1ccccc1Br
InChIInChI=1S/C21H15BrN6OS/c22-15-8-4-5-9-16(15)23-19(29)13-30-21-25-24-20-18-12-17(14-6-2-1-3-7-14)26-28(18)11-10-27(20)21/h1-12H,13H2,(H,23,29)
InChIKeyOTXNSDBIHBMHKJ-UHFFFAOYSA-N
MW479.36 g/mol
LogP4.54
Rot. Bonds5

About N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide

N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide (PubChem CID 50786995) has the molecular formula C21H15BrN6OS and a molecular weight of 479.36 g/mol. Its IUPAC name is N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide.

Molecular Properties

Compound NameN-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide
PubChem CID50786995
Molecular FormulaC21H15BrN6OS
Molecular Weight479.36 g/mol
Exact Mass478.02
IUPAC NameN-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide
SMILESO=C(CSc1nnc2c3cc(-c4ccccc4)nn3ccn12)Nc1ccccc1Br
InChIInChI=1S/C21H15BrN6OS/c22-15-8-4-5-9-16(15)23-19(29)13-30-21-25-24-20-18-12-17(14-6-2-1-3-7-14)26-28(18)11-10-27(20)21/h1-12H,13H2,(H,23,29)
InChIKeyOTXNSDBIHBMHKJ-UHFFFAOYSA-N
XLogP4.54
TPSA76.59 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500479.36
LogP ≤ 54.54
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide?
The IUPAC name of N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide (CID 50786995) is N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide.
What is the SMILES notation for N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide?
The canonical SMILES for N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide is O=C(CSc1nnc2c3cc(-c4ccccc4)nn3ccn12)Nc1ccccc1Br.
What is the InChIKey of N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide?
The InChIKey is OTXNSDBIHBMHKJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H15BrN6OS/c22-15-8-4-5-9-16(15)23-19(29)13-30-21-25-24-20-18-12-17(14-6-2-1-3-7-14)26-28(18)11-10-27(20)21/h1-12H,13H2,(H,23,29).
What are the key properties of N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide?
N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide has a molecular weight of 479.36 g/mol, XLogP of 4.54, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-bromophenyl)-2-[(11-phenyl-3,4,6,9,10-pentazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,10-pentaen-5-yl)sulfanyl]acetamide is sourced from PubChem (CID 50786995), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).